Organigram Global Expands FAST(TM) Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity
MWN-AI** Summary
Organigram Global Inc. (NASDAQ: OGI) has announced the launch of SHRED Shotz, a new single-serve cannabis beverage that harnesses their FAST™ nanoemulsion technology. This 65ml compact beverage is designed to deliver effects in approximately 15 minutes, marking a significant advancement in the efficiency of cannabinoid delivery. SHRED Shotz aims to expand the already popular SHRED brand, which achieved over $200 million in retail sales in 2025, demonstrating its strength in the market.
The introduction of SHRED Shotz is part of Organigram's strategy to innovate within the beverage category and attract new consumers. Eric Williams, Vice President of Marketing at Organigram, emphasized the importance of consumer insights driving this product development, making sure it combines taste, convenience, and predictability.
The FAST™ technology, which underpins SHRED Shotz, is a patent-pending platform noted for enabling quicker onset times and improved bioavailability compared to traditional cannabis products. Clinical studies have shown that FAST™ can provide up to 50% faster onset and enhanced cannabinoid absorption, significantly improving the consumer experience.
Expected to launch in March, SHRED Shotz will initially be available in Ontario and Atlantic Canada, with plans for broader distribution throughout other provinces following. Each bottle contains 10 mg of THC and will be offered in two flavors: Blue Razzberry and OG Lemonade.
Organigram Global, a leader in the cannabis sector, operates multiple cultivation and processing facilities across Canada. The company remains focused on high-quality product development while exploring international business opportunities to strengthen its global presence in the evolving cannabis market.
MWN-AI** Analysis
Organigram Global Inc. (NASDAQ: OGI) continues to assert its position as a leader in the Canadian cannabis market with the expansion of its SHRED brand through the introduction of SHRED Shotz, a convenient 65ml single-serve beverage powered by its FAST™ nanoemulsion technology. This development is a strategic maneuver in the highly competitive cannabis beverage sector, which has been gaining traction among consumers seeking alternative consumption methods.
SHRED Shotz is positioned to appeal to a broader audience, especially given the product's rapid onset and convenience—attributes that could significantly enhance consumer experience and loyalty. Notably, with the SHRED brand recently surpassing $200 million in retail sales, it demonstrates strong brand equity that Organigram can leverage to capture a larger market share in the beverage category.
From an investment perspective, this product launch represents an opportunity for potential revenue growth and market capture. Organigram's focus on product innovation reflects a commitment to staying relevant amid changing consumer preferences. Fast-acting beverages are gaining popularity, and SHRED Shotz appears well-timed to meet that demand. The market's initial reception will be vital; monitoring sales performance post-launch—and subsequent reactions from consumers—will provide insights into the potential longevity and success of this product line.
Investors should stay attuned to the company's operational efficiencies and supply chain capabilities. Given Organigram’s established production facilities across Canada, the efficient rollout of SHRED Shotz could position the company advantageously, primarily as it navigates regulatory challenges and competitive pressures in a rapidly evolving market landscape. Ultimately, stakeholder sentiment should be gauged closely as market conditions fluctuate, ensuring a comprehensive evaluation of the company's trajectory within the burgeoning cannabis sector.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
FAST™-powered SHRED Shotz extends the SHRED brand into shot-sized beverages
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada’s #1 cannabis company by market share 1 is pleased to announce the launch of SHRED Shotz, a compact, single-serve 65ml cannabis beverage powered by FAST™, Organigram’s fast-acting nanoemulsion technology platform designed to deliver a 15-minute onset 2 .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305717369/en/
This launch reflects Organigram’s focus on differentiated innovation while leveraging the scale of SHRED, one of the Company’s best-known brands. SHRED surpassed $200 million in retail sales in 2025 3 , underscoring the brand’s momentum and track record of expansion into new formats. With SHRED Shotz, Organigram is introducing a compact format designed to help broaden the beverage category and bring new consumers into the segment.
“SHRED Shotz is another clear example of how we successfully translate consumer insights into meaningful product innovation,” said Eric Williams, Organigram Global’s Vice President of Marketing. “With FAST™ powering the formulation, we are bringing that technology into a compact, single-serve beverage under the SHRED brand, allowing us to expand into new occasions with a format built for taste, convenience and predictability.”
About FAST™ nanoemulsion technology
FAST™ is a patent-pending nanoemulsion technology platform designed to support a faster-onset ingestible experience and consistent performance across product formats. Organigram has previously reported clinical pharmacokinetic (PK) research completed through the Product Development Collaboration, a joint research and development initiative with BAT, showing that, depending on the ingestible format, FAST™ delivered up to approximately 50% faster onset, improved bioavailability (the amount absorbed into the bloodstream), and up to double cannabinoid delivery at peak compared with traditional ingestible products 4 .
SHRED Shotz are expected to be available for sale at Canadian cannabis retailers sometime in March in Ontario and Atlantic Canada, with availability in other provinces expected to follow soon after. Each compact 65 mL bottle contains 10 mg THC and will be available in Blue Razzberry and OG Lemonade flavours.
About Organigram Global Inc.
Organigram Global Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. Through its acquisition of Collective Project, Organigram Global participates in the U.S. and Canadian cannabinoid beverage markets. Organigram is focused on producing high-quality cannabis for adult consumers, as well as developing international business relationships to extend the Company's global footprint. Organigram has developed and acquired a portfolio of cannabis brands, including Edison, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Tremblant Cannabis, Collective Project, Trailblazer, BOXHOT and DEBUNK. Organigram operates cultivation and processing facilities in Moncton, New Brunswick and Lac Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company operates two additional cannabis processing facilities in Southwestern Ontario; one in Aylmer and the other in London. The facility in Aylmer houses best-in-class CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labelling, packaging, and national fulfillment. The Company is regulated by Health Canada under the Cannabis Act and the Cannabis Regulations (Canada).
Forward-Looking Information
This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or statements that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information including expectations regarding market performance involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram Global to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include timing for launch of products, changes in the regulatory landscape, acceptance of products and different product forms in the local market and factors and risks disclosed in the Company’s most recent annual information form, management’s discussion and analysis, and other Company documents filed from time to time on SEDAR+ (see www.sedarplus.ca ) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov ). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed timeframes or at all. The forward-looking information included in this news release is made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
| _________________________ |
1 Based on multiple sources (Hifyre, Weedcrawler, provincial boards, internal modelling) as of December 30, 2025. |
2 Onset is defined in terms of mean blood concentrations. Onset times may vary. |
3 Based on multiple sources (Hifyre, Weedcrawler, provincial boards, internal modelling) as of September 30, 2025. |
4 Preliminary PK study results released August 07, 2024. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20260305717369/en/
Media Contact
Max Schwartz, Director of Investor Relations investors@organigram.ca
Mark McKay, Director of Communications mark.mckay@organigram.ca
FAQ**
How does Organigram Holdings Inc. OGI plan to leverage its FAST™ technology to differentiate SHRED Shotz in an increasingly competitive cannabis beverage market?
What marketing strategies will Organigram Holdings Inc. OGI employ to attract new consumers to the SHRED Shotz brand, particularly in Ontario and Atlantic Canada?
Can you discuss the anticipated consumer response to the SHRED Shotz flavors, Blue Razzberry and OG Lemonade, and how Organigram Holdings Inc. OGI plans to measure this?
What challenges does Organigram Holdings Inc. OGI foresee in terms of regulatory changes that might impact the launch and acceptance of SHRED Shotz in various Canadian provinces?
**MWN-AI FAQ is based on asking OpenAI questions about Organigram Holdings Inc. (TSXC: OGI:CC).
NASDAQ: OGI:CC
OGI:CC Trading
6.57% G/L:
$1.46 Last:
544,710 Volume:
$1.37 Open:
